Kazuharu Igarashi
Kazuharu Igarashi publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #3,927,856 of 7,710,434 ranked researchers
- Rank in Japan
- #103,812 of 383,136
- Works
- 64
- Citations
- 751
- Citations per work
- 11.7
What does Kazuharu Igarashi research?
Kazuharu Igarashi's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4977.3%
- Medicine4977.3%
- Everything else1016.1%
- Life Sciences46.6%
- 1Surgery29% of their works
- 2Oncology18% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Hepatology11% of their works
- 5Molecular Biology7% of their works
- 6Epidemiology5% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Epigenetics and DNA Methylation
- Colorectal Cancer Surgical Treatments
- Minimally Invasive Surgical Techniques
- Gastric Cancer Management and Outcomes
- Organ Transplantation Techniques and Outcomes
Which keywords describe Kazuharu Igarashi's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Neoadjuvant Therapy, Chemotherapy, Pancreatic Cancer, Surgical Complications, Hepatocellular Carcinoma, Liver Cancer and Biliary Tract Cancer.
- Ischemia-Reperfusion Injury
- Endoscopic Resection
- Single-Incision Laparoscopy
- Preoperative Chemoradiotherapy
- DNA Methylation
- Biliary Tract Cancer
- Hepatocellular Carcinoma
- Pancreatic Cancer
- Neoadjuvant Therapy
- Clinical Practice Guidelines
- Chemotherapy
- Surgical Complications
- Liver Cancer
- Cholangiocarcinoma
- Histone Modification
- Rectal Cancer
- Transgastric Surgery
- Gastric Cancer
- Liver Transplantation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Clinical Practice Guidelines303 topics
- Neoadjuvant Therapy252 topics
- Chemotherapy242 topics
- Pancreatic Cancer181 topic
- Surgical Complications181 topic
- Hepatocellular Carcinoma171 topic
- Liver Cancer171 topic
- Biliary Tract Cancer151 topic
- Cholangiocarcinoma151 topic
- DNA Methylation71 topic
- Histone Modification71 topic
- Preoperative Chemoradiotherapy71 topic
- Rectal Cancer71 topic
- Single-Incision Laparoscopy71 topic
- Transgastric Surgery71 topic
- Endoscopic Resection61 topic
- Gastric Cancer61 topic
- Ischemia-Reperfusion Injury51 topic
- Liver Transplantation51 topic
Where does Kazuharu Igarashi work?
Kazuharu Igarashi's main affiliation in the publication record is Hakodate Central General Hospital, Japan.
How many publications and citations does Kazuharu Igarashi have?
OpenAlex counts 64 works and 751 citations for Kazuharu Igarashi, an h-index of 13, ranking #3,927,856 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kazuharu Igarashi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.